Chemotherapy for advanced disease: How to raise enthusiasm

Chest

Volumn 109, Issue 5 SUPPL., 1996, Pages

  McVie, J Gordon ^a,b  

^a European Organization for Research and Treatment of Cancer (EORTC)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; NAVELBINE; VINDESINE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL STUDY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; HUMAN; INTERNATIONAL COOPERATION; LUNG NON SMALL CELL CANCER; META ANALYSIS; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ATTITUDE; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COMMUNICATION; HUMANS; LUNG NEOPLASMS; SMOKING;

EID: 0029916860     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339:1-15
2. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992; 339:71-85
3. Raby B, Pater J, Mackillop WJ. A summary of Canadian physicians' beliefs about the use of radiation and chemotherapy in non-small cell lung cancer. The Proceedings of the Annual Meeting of the American Society of Clinical Oncology 1994; 13(suppl A):1079
4. Slevin ML, Stubbs L, Plant HJ, et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 1990; 300:1458-60
5. le Chevalier T. Chemotherapy for advanced disease - will meta-analysis provide the answer? Chest 1996; 109:107S-109S